Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for E-Cigarette Cessation
NCT07040566Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Oct 2025
- Primary completion
- Jul 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in nicotine dependence, sponsored by Yale University. Started Oct 2025; status: recruiting.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT07040566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07040566.